Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells

Human Molecular Genetics

Volumn 24, Issue 5, 2015, Pages 1432-1440

  Gómez Úriz, Ana M ^a   Milagro, Fermín I ^a,b   Mansego, María L ^a,b   Cordero, Paúl ^a   Abete, Itziar ^c   De Arce, Ana ^d   Goyenechea, Estíbaliz ^c   Blázquez, Vanessa ^c   Martínez Zabaleta, Maite ^d,e   Martínez, José Alfredo ^a,b   De Munain, Adolfo López ^c,d,e,f   Campión, Javier ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^d HOSPITAL DONOSTIA   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALDESMON; CALDESMON 1; DNA; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG; WT1 PROTEIN; CALMODULIN; CALMODULIN BINDING PROTEIN; GENETIC MARKER; KCNQ1 PROTEIN, HUMAN; METALLOPROTEINASE; WT1 PROTEIN, HUMAN;

AGED; ARTICLE; BODY MASS; BODY WEIGHT; BRAIN ISCHEMIA; CASE CONTROL STUDY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; STROKE PATIENT; BLOOD; CEREBROVASCULAR ACCIDENT; CPG ISLAND; GENETIC EPIGENESIS; GENETIC MARKER; GENETICS; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

AGED; BODY MASS INDEX; CALMODULIN; CALMODULIN-BINDING PROTEINS; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC MARKERS; HUMANS; KCNQ1 POTASSIUM CHANNEL; LEUKOCYTES; LINEAR MODELS; MALE; METALLOPROTEASES; MIDDLE AGED; OBESITY; PROMOTER REGIONS, GENETIC; STROKE; WT1 PROTEINS;

EID: 84924455466     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu559     Document Type: Article

References (63)

1. Marti, A., Martinez-Gonzalez, M.A. and Martinez, J.A. (2008) Interaction between genes and lifestyle factors on obesity. Proc. Nutr. Soc., 67, 1-8.
2. Strong, K., Mathers, C. and Bonita, R. (2007) Preventing stroke:saving lives around the world. Lancet Neurol., 6, 182-187.
3. Gulsvik, A.K., Thelle, D.S., Samuelsen, S.O., Myrstad, M., Mowe, M. and Wyller, T.B. (2012) Ageing, physical activity and mortality-a 42-year follow-up study. Int. J. Epidemiol., 41, 521-530.
4. Xu, T., Bu, X., Li, H., Zhang, M.,Wang, A., Tong,W., Sun, Y. and Zhang, Y. (2013) Smoking, heart rate, and ischemic stroke: a population-based prospective cohort study among Inner Mongolians in China. Stroke, 44, 2457-2461.
5. Teo, K.K., Goldstein, L.B., Chaitman, B.R., Grant, S., Weintraub, W.S., Anderson, D.C., Sila, C.A., Cruz-Flores, S., Padley, R.J., Kostuk, W.J. et al. (2013) Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. Stroke, 44, 2688-2693.
6. Abete, I., Navas-Carretero, S., Marti, A. and Martinez, J.A. (2012) Nutrigenetics and nutrigenomics of caloric restriction. Prog. Mol. Biol. Transl. Sci., 108, 323-346.
7. Fox, C.S., Pencina, M.J., Heard-Costa, N.L., Shrader, P., Jaquish, C., O'Donnell, C.J., Vasan, R.S., Cupples, L.A. and D'Agostino, R.B. (2014) Trends in the association of parental history of obesity over 60 years. Obesity (Silver Spring), 22, 919-924.
8. Stepanyan, A., Zakharyan, R. and Boyajyan, A. (2013) The netrin G1 gene rs628117 polymorphism is associated with ischemic stroke. Neurosci. Lett., 549, 74-77.
9. Rankinen, T., Zuberi, A., Chagnon, Y.C.,Weisnagel, S.J., Argyropoulos, G.,Walts, B., Perusse, L. and Bouchard, C. (2006) The human obesity gene map: the 2005 update. Obesity (Silver Spring), 14, 529-644.
10. Feinberg, A.P. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature, 447, 433-440.
11. Milagro, F.I., Mansego, M.L., De Miguel, C. and Martinez, J.A. (2013) Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol. Aspects Med., 34, 782-812.
12. Esteller, M. (2008) Epigenetics in cancer. N. Engl. J. Med., 358, 1148-1159.
13. Hermsdorff, H.H., Mansego, M.L., Campion, J., Milagro, F.I., Zulet, M.A. and Martinez, J.A. (2013) TNF-alpha promoter methylation in peripheral white blood cells: relationship with circulating TNFalpha, truncal fat and n-6 PUFA intake in young women. Cytokine, 64, 265-271.
14. Cordero, P., Campion, J., Milagro, F.I., Goyenechea, E., Steemburgo, T., Javierre, B.M. and Martinez, J.A. (2011) Leptin and TNF-alpha promoter methylation levels measured by MSP could predict the response to a low-calorie diet. J. Physiol. Biochem., 67, 463-470.
15. Chen, E.S., Ernst, C. andTurecki,G. (2011) The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression. Int. J. Neuropsychopharmacol., 14, 427-429.
16. Qureshi, I.A. and Mehler, M.F. (2010) The emerging role of epigenetics in stroke: II. RNA regulatory circuitry. Arch. Neurol., 67, 1435-1441.
17. Schweizer, S., Meisel, A. and Marschenz, S. (2013) Epigenetic mechanisms in cerebral ischemia. J. Cereb. Blood Flow Metab., 33, 1335-1346.
18. Kalani, A., Kamat, P.K., Tyagi, S.C. and Tyagi, N. (2013) Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke. Mol. Neurobiol., 48, 157-168.
19. Terry, M.B., Delgado-Cruzata, L., Vin-Raviv, N., Wu, H.C. and Santella, R.M. (2011) DNA methylation in white blood cells:association with risk factors in epidemiologic studies. Epigenetics, 6, 828-837.
20. Baccarelli, A.,Wright, R., Bollati, V., Litonjua, A., Zanobetti, A., Tarantini, L., Sparrow, D., Vokonas, P. and Schwartz, J. (2010) Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology, 21, 819-828.
21. Preiss, D., Giles, T.D., Thomas, L.E., Sun, J.L., Haffner, S.M., Holman, R.R., Standl, E., Mazzone, T., Rutten, G.E., Tognoni, G. et al. (2013) Predictors of stroke in patients with impaired glucose tolerance: results fromthe Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Stroke, 44, 2590-2593.
22. Karcher, H.S., Holzwarth, R., Mueller, H.P., Ludolph, A.C., Huber, R., Kassubek, J. and Pinkhardt, E.H. (2013) Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc. Dis., 35, 341-348.
23. Rundek, T., Gardener, H., Xu, Q., Goldberg, R.B., Wright, C.B., Boden-Albala, B., Disla, N., Paik, M.C., Elkind, M.S. and Sacco, R.L. (2010) Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch. Neurol., 67, 1195-1200.
24. Kuramitsu, S., Yokoi, H., Domei, T., Nomura, A.,Watanabe, H., Yamaji, K., Soga, Y., Arita, T., Kondo, K., Shirai, S. et al. (2013) Impact of post-challenge hyperglycemia on clinical outcomes in Japanese patients with stable angina undergoing percutaneous coronary intervention. Cardiovasc. Diabetol., 12, 74.
25. Wardlaw, J.M., Sandercock, P.A. and Murray, V. (2009) Should more patients with acute ischaemic stroke receive thrombolytic treatment? BMJ, 339, b4584.
26. Kuroda, A., Rauch, T.A., Todorov, I., Ku, H.T., Al-Abdullah, I.H., Kandeel, F., Mullen, Y., Pfeifer, G.P. and Ferreri, K. (2009) Insulin gene expression is regulated by DNA methylation. PLoS One, 4, e6953.
27. Jander, S., Kraemer, M., Schroeter, M.,Witte, O.W. and Stoll, G. (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab., 15, 42-51.
28. Buck, B.H., Liebeskind, D.S., Saver, J.L., Bang, O.Y., Yun, S.W., Starkman, S., Ali, L.K., Kim, D., Villablanca, J.P., Salamon, N. et al. (2008) Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke, 39, 355-360.
29. Kriz, J. and Lalancette-Hebert, M. (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol., 117, 497-509.
30. Mo, X., Li, T., Ji, G., Lu, W. and Hu, Z. (2013) Peripheral polymorphonuclear leukocyte activation as a systemic inflammatory response in ischemic stroke. Neurol. Sci., 34, 1509-1516.
31. Carvalheira, J.B., Qiu, Y. and Chawla, A. (2013) Blood spotlight on leukocytes and obesity. Blood, 122, 3263-3267.
32. Snyder-Cappione, J.E. and Nikolajczyk, B.S. (2013) When diet and exercise are not enough, think immunomodulation. Mol. Aspects Med., 34, 30-38.
33. Marzullo, P., Minocci, A., Giarda, P., Marconi, C., Tagliaferri, A., Walker, G.E., Scacchi, M., Aimaretti, G. and Liuzzi, A. (2014) Lymphocytes and immunoglobulin patterns across the threshold of severe obesity. Endocrine, 45, 392-400.
34. Toperoff, G., Aran, D., Kark, J.D., Rosenberg, M., Dubnikov, T., Nissan, B., Wainstein, J., Friedlander, Y., Levy-Lahad, E., Glaser, B. et al. (2012) Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet., 21, 371-383.
35. Campion, J., Milagro, F. and Martinez, J.A. (2010) Epigenetics and obesity. Prog. Mol. Biol. Transl. Sci., 94, 291-347.
36. Milagro, F.I., Campion, J., Cordero, P., Goyenechea, E., Gomez-Uriz, A.M., Abete, I., Zulet, M.A. and Martinez, J.A. (2011) A dual epigenomic approach for the search of obesity biomarkers:DNA methylation in relation to diet-induced weight loss. FASEB J., 25, 1378-1389.
37. Paternain, L., Batlle, M.A., De la Garza, A.L., Milagro, F.I., Martinez, J.A. and Campion, J. (2012) Transcriptomic and epigenetic changes in the hypothalamus are involved in an increased susceptibility to a high-fat-sucrose diet in prenatally stressed female rats. Neuroendocrinology, 96, 249-260.
38. Kim, J.M., Stewart, R., Park, M.S., Kang, H.J., Kim, S.W., Shin, I. S., Kim, H.R., Shin, M.G., Cho, K.H. and Yoon, J.S. (2012) Associations of BDNF genotype and promoter methylation with acute and long-term stroke outcomes in an East Asian cohort. PLoS One, 7, e51280.
39. Moleres, A., Campion, J., Milagro, F.I., Marcos, A., Campoy, C., Garagorri, J.M., Gomez-Martinez, S., Martinez, J.A., Azcona-Sanjulian, M.C. and Marti, A. (2013) Differential DNA methylation patterns between high and low responders to a weight loss intervention in overweight or obese adolescents: the EVASYON study. FASEB J., 27, 2504-2512.
40. Masliah, E., Dumaop, W., Galasko, D. and Desplats, P. (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics, 8, 1030-1038.
41. Fischbach, B.V., Trout, K.L., Lewis, J., Luis, C.A. and Sika, M. (2005) WAGR syndrome: a clinical review of 54 cases. Pediatrics, 116, 984-988.
42. Mayanagi, T. and Sobue, K. (2011) Diversification of caldesmon- linked actin cytoskeleton in cell motility. Cell Adh. Migr., 5, 150-159.
43. Feinberg, A.P., Irizarry, R.A., Fradin, D., Aryee, M.J., Murakami, P., Aspelund, T., Eiriksdottir, G., Harris, T.B., Launer, L., Gudnason, V. et al. (2010) Personalized epigenomic signatures that are stable over time and covary with body mass index. Sci. Transl. Med., 2, 49ra67.
44. Suderman, M., Borghol, N., Pappas, J.J., Pinto Pereira, S.M., Pembrey, M., Hertzman, C., Power, C. and Szyf, M. (2014) Childhood abuse is associated with methylation of multiple loci in adult DNA. BMC Med. Genomics, 7, 13.
45. Sun, Q., Song, K., Shen, X. and Cai, Y. (2012) The association between KCNQ1 gene polymorphism and type 2 diabetes risk: a meta-analysis. PLoS One, 7, e48578.
46. Schwartz, P.J. and Volders, P.G. (2014) Sudden death by stress:how far under the nerves should we dig to find out why LQT1 patients die? J. Am. Coll. Cardiol., 63, 828-830.
47. Adalsteinsson, B.T., Gudnason, H., Aspelund, T., Harris, T.B., Launer, L.J., Eiriksdottir, G., Smith, A.V. and Gudnason, V. (2012) Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS One, 7, e46705.
48. Garden, G.A. (2013) Epigenetics and the modulation of neuroinflammation. Neurotherapeutics, 10, 782-788.
49. Crujeiras, A.B., Campion, J., Diaz-Lagares, A., Milagro, F.I., Goyenechea, E., Abete, I., Casanueva, F.F. and Martinez, J.A. (2013) Association of weight regain with specific methylation levels in the NPY and POMC promoters in leukocytes of obese men: a translational study. Regul. Pept., 186, 1-6.
50. Farkas, D.H., Miltgen, N.E., Stoerker, J., van den Boom, D., Highsmith, W.E., Cagasan, L., McCullough, R., Mueller, R., Tang, L., Tynan, J. et al. (2010) The suitability of matrix assisted laser desorption/ionization time of flight mass spectrometry in a laboratory developed test using cystic fibrosis carrier screening as a model. J. Mol. Diagn., 12, 611-619.
51. Wang, L., Zhu, Y.P. and Li, M.X. (2011) Role of hypoxiainducible factor-1alpha endothelin-1 and inducible nitric oxide synthase in the pathogenesis of hypoxia-induced pulmonary hypertension of the newborn. Zhongguo Dang Dai Er Ke Za Zhi, 13, 8-11.
52. Minami, Y., Ode, K.L. and Ueda, H.R. (2013) Mammalian circadian clock: the roles of transcriptional repression and delay. Handb. Exp. Pharmacol., 217, 359-377.
53. Fujimoto, Y., Shimoyama, A., Saeki, A., Kitayama, N., Kasamatsu, C., Tsutsui, H. and Fukase, K. (2013) Innate immunomodulation by lipophilic termini of lipopolysaccharide; synthesis of lipid As from Porphyromonas gingivalis and other bacteria and their immunomodulative responses. Mol. Biosyst., 9, 987-996.
54. Egg, M., Koblitz, L., Hirayama, J., Schwerte, T., Folterbauer, C., Kurz, A., Fiechtner, B., Most, M., Salvenmoser, W., Sassone-Corsi, P. et al. (2013) Linking oxygen to time: the bidirectional interaction between the hypoxic signaling pathway and the circadian clock. Chronobiol. Int., 30, 510-529.
55. Woo, D., Broderick, J.P., Kothari, R.U., Lu, M., Brott, T., Lyden, P.D., Marler, J.R. and Grotta, J.C. (1999) Does the National Institutes of Health Stroke Scale favor left hemisphere strokes? NINDS t-PA Stroke Study Group. Stroke, 30, 2355-2359.
56. Whitworth, J.A. and Chalmers, J. (2004)World Health Organisation-International Society of Hypertension (WHO/ISH) hypertension guidelines. Clin. Exp. Hypertens., 26, 747-752.
57. Wettenhall, J.M. and Smyth, G.K. (2004) limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics, 20, 3705-3706.
58. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B, 57, 289-300.
59. Stefanska, B., Bouzelmat, A., Huang, J., Suderman, M., Hallett, M., Han, Z.G., Al-Mahtab, M., Akbar, S.M., Khan, W.A., Raqib, R. et al. (2013) Discovery and validation of DNA hypomethylation biomarkers for liver cancer using HRM-specific probes. PLoS One, 8, e68439.
60. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, Research0034-0034.11.
61. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
62. Cartharius, K., Frech, K., Grote, K., Klocke, B., Haltmeier, M., Klingenhoff, A., Frisch, M., Bayerlein, M. and Werner, T. (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics, 21, 2933-2942.
63. Rustici, G., Kolesnikov, N., Brandizi, M., Burdett, T., Dylag, M., Emam, I., Farne, A., Hastings, E., Ison, J., Keays, M. et al. (2013) ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res., 41, D987-D990.